Skip to main content
. 2023 Oct 21;13(12):8259–8273. doi: 10.21037/qims-23-541

Table 3. Comparisons between the IDH1-mutant group and the IDH1-wild-type group in LrGGs and GBMs.

Metric IDH1 wild-type IDH1 mutant P value
LrGG
   ALPS-index 1.400±0.185 1.530±0.123 0.036
   FA-tumor 0.153±0.060 0.112±0.046 0.015
   MD-tumor 1.103±0.313 1.426±0.359 0.019
   MK-tumor 0.627±0.193 0.462±0.114 0.003
   FA-edema 0.193±0.076 0.169±0.065 0.364
   MD-edema 1.332±0.340 1.485±0.199 0.144
   MK-edema 0.549±0.118 0.489±0.068 0.129
GBM
   ALPS-index 1.300±0.169 1.380±0.110 0.175
   FA-tumor 0.174±0.111 0.142±0.075 0.448
   MD-tumor 0.985±0.247 0.947±0.300 0.781
   MK-tumor 0.685±0.170 0.690±0.187 0.999
   FA-edema 0.194±0.081 0.183±0.071 0.736
   MD-edema 1.421±0.279 1.249±0.350 0.186
   MK-edema 0.535±0.096 0.579±0.143 0.274

Data are presented as mean ± standard deviation. MD is in units of 10−3 mm2/s. IDH1, isocitrate dehydrogenase 1; LrGG, lower-grade glioma; GBM, glioblastoma; ALPS, analysis along the perivascular space; FA, fractional anisotropy; MD, mean diffusivity; MK, mean kurtosis.